JAMA oncology Journal

Overview
Identity
View All

publication venue for

Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.. 10:896-904. 2024
Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A Review.. 10:240-248. 2024
Miscommunication in Cancer Care-Do You Hear What I Hear?. 9:1335-1336. 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.. 9:1390-1400. 2023
The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019.. 9:1401-1416. 2023
Net Clinical Benefit as Measure of Treatment Benefit Among Older Adults With Advanced Incurable Non-Small Cell Lung Cancer-Reply.. 9:1154-1155. 2023
Blood Clots, or Thrombosis, in Patients With Cancer.. 9:-. 2023
Clinical Trial Diversity-Will We Know It When We See It?. 9:765-767. 2023
Association Between Age and Survival Trends in Advanced Non-Small Cell Lung Cancer After Adoption of Immunotherapy.. 9:334-341. 2023
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.. 9:206-214. 2023
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.. 9:128-134. 2023
Addressing Racial, Ethnic, and Age Disparities in Cancer Clinical Trial Enrollment: Time to Stop Tinkering Around the Edges.. 8:1792-1793. 2022
Systemic Anticancer Therapy at the End of Life-Changes in Usage Pattern in the Immunotherapy Era.. 8:1847-1849. 2022
Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.. 8:687-696. 2022
Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer-Reply.. 8:-. 2022
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.. 8:420-444. 2022
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.. 7:1856-1861. 2021
Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.. 7:-. 2021
Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers: Review and Research Recommendations.. 7:1692-1699. 2021
Is Colorectal Cancer Screening Absolutely Beneficial for Older Adults?. 7:-. 2021
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population.. 7:1723-1724. 2021
Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement.. 7:609-615. 2021
Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer.. 7:52-58. 2021
Risk-Benefit Comparisons Between Shorter and Longer Durations of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer.. 6:1301-1302. 2020
Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer.. 6:1121-1122. 2020
Global Retinoblastoma Presentation and Analysis by National Income Level.. 6:685-695. 2020
Association of Early Palliative Care With Survival in Patients With Advanced Lung Cancer-Reply.. 6:443-444. 2020
Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program.. 6:196-204. 2020
Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration.. 5:1702-1709. 2019
Treatment-Related Complications of Systemic Therapy and Radiotherapy.. 5:1028-1035. 2019
Methodology Flaws and Implications of a Complementary Medicine Study-In Reply.. 5:-. 2019
Effect of Apoyo con Cariño (Support With Caring) Trial of a Patient Navigator Intervention to Improve Palliative Care Outcomes for Latino Adults With Advanced Cancer: A Randomized Clinical Trial.. 4:1736-1741. 2018
Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.. 4:1375-1381. 2018
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.. 4:-. 2018
Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma.. 4:1135-1136. 2018
Preferred Clinician Communication About Stopping Cancer Screening Among Older US Adults: Results From a National Survey.. 4:1126-1128. 2018
Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia.. 4:-. 2018
Evaluating Treatment Effect Based on Duration of Response for a Comparative Oncology Study.. 4:874-876. 2018
Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study.. 4:881-882. 2018
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.. 4:54-62. 2018
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.. 3:1692-1696. 2017
Sickness.. 3:-. 2017
Negative Studies in Cancer Research: Why the Negativity?. 2:865-6. 2016
Cancer Communication in the Social Media Age.. 2:822-3. 2016
Targeting the Cancer Moonshot.. 2:421-2. 2016
A Call for Value in Cancer Research.. 2:11-2. 2016
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.. 1:778-84. 2015
Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.. 1:185-94. 2015